Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1335
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Should MMMT still be treated with adjuvant taxane-based combination chemotherapy? ; volume:146 ; number:3 ; day:28 ; month:1 ; year:2020 ; pages:695-704 ; date:3.2020
Journal of cancer research and clinical oncology ; 146, Heft 3 (28.1.2020), 695-704, 3.2020
- Creator
-
Heinzelmann-Schwarz, Viola Angelika
Kind, André B.
Vetter, Marcus
Russell, Kenneth
Omar, Siti
Schoetzau, Andreas
Hoeck, Kerstin
Fink, Daniel
Friedlander, Michael L.
Hacker, Neville F.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00432-019-03091-y
- URN
-
urn:nbn:de:101:1-2020051905465751102568
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heinzelmann-Schwarz, Viola Angelika
- Kind, André B.
- Vetter, Marcus
- Russell, Kenneth
- Omar, Siti
- Schoetzau, Andreas
- Hoeck, Kerstin
- Fink, Daniel
- Friedlander, Michael L.
- Hacker, Neville F.
- SpringerLink (Online service)
Other Objects (12)
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Taxane Combination Chemotherapy in Breast Cancer: Experience from a Tertiary Cancer Centre in India
A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling
Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials
Combination of neoadjuvant and adjuvant chemotherapy with FOLFOX compared with adjuvant chemotherapy in management of locally advanced rectal cancers: a randomized trial of a promising therapeutic approach
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Re-challenging taxanes in recurrent breast cancer in patients treated with (neo-)adjuvant taxane-based therapy
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Taxane Combination Chemotherapy in Breast Cancer: Experience from a Tertiary Cancer Centre in India
A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling
Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials
Combination of neoadjuvant and adjuvant chemotherapy with FOLFOX compared with adjuvant chemotherapy in management of locally advanced rectal cancers: a randomized trial of a promising therapeutic approach
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Re-challenging taxanes in recurrent breast cancer in patients treated with (neo-)adjuvant taxane-based therapy
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Taxane Combination Chemotherapy in Breast Cancer: Experience from a Tertiary Cancer Centre in India
A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling
Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials
Combination of neoadjuvant and adjuvant chemotherapy with FOLFOX compared with adjuvant chemotherapy in management of locally advanced rectal cancers: a randomized trial of a promising therapeutic approach
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Re-challenging taxanes in recurrent breast cancer in patients treated with (neo-)adjuvant taxane-based therapy